Characteristics of People Who Inject Drugs Hospitalized for Injection Drug Use-associated Infections in Florida, 2016–2017, Stratified by Substance Used
Characteristic . | Overall, n (%) N = 22 856 . | Opioids-only, n (%) n = 13 039 . | Stimulant-only, N (%) n = 6174 . | Opioid/Stimulant, N (%) n = 3643 . |
---|---|---|---|---|
Age | ||||
18–34 | 6665 (31.1) | 3310 (27.1) | 1645 (28.4) | 1710 (49.5) |
35–54 | 9347 (43.6) | 4882 (40.0) | 2971 (51.3) | 1494 (43.2) |
55–64 | 3896 (18.2) | 2648 (21.7) | 1018 (17.6) | 230 (6.7) |
65–75 | 1554 (7.3) | 1375 (11.3) | 155 (2.7) | 24 (0.7) |
Age (median, IQR) | 44 (33–56) | 47 (34–58) | 44 (34–54) | 35 (29–44) |
Male | 12 266 (53.7) | 6675 (51.2) | 3812 (61.7) | 1779 (49.1) |
Female | 10 574 (46.3) | 6364 (48.8) | 2362 (38.3) | 1848 (50.9) |
Race/Ethnicity | ||||
Non-Hispanic White | 17 654 (79.6) | 10 832 (85.4) | 3869 (64.6) | 2953 (84.1) |
Non-Hispanic Black | 2619 (11.8) | 892 (7.0) | 1511 (25.2) | 216 (6.2) |
Hispanic | 1914 (8.6) | 958 (7.6) | 614 (10.2) | 342 (9.7) |
Insurance | ||||
Medicare | 6968 (30.5) | 5187 (39.8) | 1324 (21.4) | 457 (12.6) |
Medicaid | 5964 (26.1) | 3030 (23.2) | 1998 (32.4) | 936 (25.8) |
Private | 2610 (11.4) | 1682 (12.9) | 545 (8.8) | 383 (10.6) |
Uninsured | 7298 (32.0) | 3140 (24.1) | 2307 (37.4) | 1851 (51.0) |
Infection | ||||
Endocarditis | 2207 (9.7) | 1238 (9.5) | 388 (6.3) | 581 (16.0) |
SSTI | 11 302 (49.5) | 6081 (46.6) | 3199 (51.8) | 2022 (55.8) |
Osteomyelitis | 3240 (14.2) | 2084 (16.0) | 709 (11.5) | 447 (12.3) |
Sepsis/Bacteremia | 11 915 (52.2) | 7062 (54.2) | 3069 (49.7) | 1784 (49.2) |
Comorbidity Present | ||||
HIV-positive | 1085 (4.8) | 295 (2.3) | 649 (10.5) | 141 (3.9) |
HCV-positive | 5925 (25.9) | 2962 (22.7) | 1350 (21.9) | 1613 (44.3) |
Heart Failure | 2268 (9.9) | 1443 (11.1) | 655 (10.6) | 170 (4.7) |
Hypertension | 8844 (38.7) | 5638 (43.2) | 2424 (39.3) | 782 (21.5) |
Chronic Pulmonary Disease | 4277 (18.7) | 2926 (22.4) | 1045 (16.9) | 306 (8.4) |
Diabetes | 4620 (20.2) | 3103 (23.8) | 1217 (19.7) | 300 (8.2) |
Renal Disease | 2577 (11.3) | 1733 (13.3) | 688 (11.1) | 156 (4.3) |
Alcohol | 2726 (11.9) | 1092 (8.4) | 1204 (19.5) | 430 (11.8) |
Psychoses | 994 (4.4) | 290 (2.2) | 537 (8.7) | 167 (4.6) |
Depression | 4879 (21.4) | 3066 (23.5) | 1088 (17.6) | 725 (19.9) |
Overdose | 1563 (6.8) | 963 (7.4) | 293 (4.8) | 307 (8.5) |
Length of stay (median, IQR) | 6.0 (3–12) | 6.0 (3–13) | 5.0 (3–10) | 5.0 (2–11) |
Disposition | ||||
Discharged | 18 572 (81.3) | 10 962 (84.1) | 4978 (80.6) | 2632 (72.3) |
In-hospital mortality | 823 (3.6) | 458 (3.5) | 264 (4.3) | 101 (2.8) |
Patient-directed discharge | 3461 (15.1) | 1619 (12.4) | 932 (15.1) | 910 (25.0) |
Characteristic . | Overall, n (%) N = 22 856 . | Opioids-only, n (%) n = 13 039 . | Stimulant-only, N (%) n = 6174 . | Opioid/Stimulant, N (%) n = 3643 . |
---|---|---|---|---|
Age | ||||
18–34 | 6665 (31.1) | 3310 (27.1) | 1645 (28.4) | 1710 (49.5) |
35–54 | 9347 (43.6) | 4882 (40.0) | 2971 (51.3) | 1494 (43.2) |
55–64 | 3896 (18.2) | 2648 (21.7) | 1018 (17.6) | 230 (6.7) |
65–75 | 1554 (7.3) | 1375 (11.3) | 155 (2.7) | 24 (0.7) |
Age (median, IQR) | 44 (33–56) | 47 (34–58) | 44 (34–54) | 35 (29–44) |
Male | 12 266 (53.7) | 6675 (51.2) | 3812 (61.7) | 1779 (49.1) |
Female | 10 574 (46.3) | 6364 (48.8) | 2362 (38.3) | 1848 (50.9) |
Race/Ethnicity | ||||
Non-Hispanic White | 17 654 (79.6) | 10 832 (85.4) | 3869 (64.6) | 2953 (84.1) |
Non-Hispanic Black | 2619 (11.8) | 892 (7.0) | 1511 (25.2) | 216 (6.2) |
Hispanic | 1914 (8.6) | 958 (7.6) | 614 (10.2) | 342 (9.7) |
Insurance | ||||
Medicare | 6968 (30.5) | 5187 (39.8) | 1324 (21.4) | 457 (12.6) |
Medicaid | 5964 (26.1) | 3030 (23.2) | 1998 (32.4) | 936 (25.8) |
Private | 2610 (11.4) | 1682 (12.9) | 545 (8.8) | 383 (10.6) |
Uninsured | 7298 (32.0) | 3140 (24.1) | 2307 (37.4) | 1851 (51.0) |
Infection | ||||
Endocarditis | 2207 (9.7) | 1238 (9.5) | 388 (6.3) | 581 (16.0) |
SSTI | 11 302 (49.5) | 6081 (46.6) | 3199 (51.8) | 2022 (55.8) |
Osteomyelitis | 3240 (14.2) | 2084 (16.0) | 709 (11.5) | 447 (12.3) |
Sepsis/Bacteremia | 11 915 (52.2) | 7062 (54.2) | 3069 (49.7) | 1784 (49.2) |
Comorbidity Present | ||||
HIV-positive | 1085 (4.8) | 295 (2.3) | 649 (10.5) | 141 (3.9) |
HCV-positive | 5925 (25.9) | 2962 (22.7) | 1350 (21.9) | 1613 (44.3) |
Heart Failure | 2268 (9.9) | 1443 (11.1) | 655 (10.6) | 170 (4.7) |
Hypertension | 8844 (38.7) | 5638 (43.2) | 2424 (39.3) | 782 (21.5) |
Chronic Pulmonary Disease | 4277 (18.7) | 2926 (22.4) | 1045 (16.9) | 306 (8.4) |
Diabetes | 4620 (20.2) | 3103 (23.8) | 1217 (19.7) | 300 (8.2) |
Renal Disease | 2577 (11.3) | 1733 (13.3) | 688 (11.1) | 156 (4.3) |
Alcohol | 2726 (11.9) | 1092 (8.4) | 1204 (19.5) | 430 (11.8) |
Psychoses | 994 (4.4) | 290 (2.2) | 537 (8.7) | 167 (4.6) |
Depression | 4879 (21.4) | 3066 (23.5) | 1088 (17.6) | 725 (19.9) |
Overdose | 1563 (6.8) | 963 (7.4) | 293 (4.8) | 307 (8.5) |
Length of stay (median, IQR) | 6.0 (3–12) | 6.0 (3–13) | 5.0 (3–10) | 5.0 (2–11) |
Disposition | ||||
Discharged | 18 572 (81.3) | 10 962 (84.1) | 4978 (80.6) | 2632 (72.3) |
In-hospital mortality | 823 (3.6) | 458 (3.5) | 264 (4.3) | 101 (2.8) |
Patient-directed discharge | 3461 (15.1) | 1619 (12.4) | 932 (15.1) | 910 (25.0) |
Abbreviations: HCV, hepatitis C virus; HIV, human immunodeficiency virus; IQR, interquartile range; SSTI, skin and soft tissue infection.
Characteristics of People Who Inject Drugs Hospitalized for Injection Drug Use-associated Infections in Florida, 2016–2017, Stratified by Substance Used
Characteristic . | Overall, n (%) N = 22 856 . | Opioids-only, n (%) n = 13 039 . | Stimulant-only, N (%) n = 6174 . | Opioid/Stimulant, N (%) n = 3643 . |
---|---|---|---|---|
Age | ||||
18–34 | 6665 (31.1) | 3310 (27.1) | 1645 (28.4) | 1710 (49.5) |
35–54 | 9347 (43.6) | 4882 (40.0) | 2971 (51.3) | 1494 (43.2) |
55–64 | 3896 (18.2) | 2648 (21.7) | 1018 (17.6) | 230 (6.7) |
65–75 | 1554 (7.3) | 1375 (11.3) | 155 (2.7) | 24 (0.7) |
Age (median, IQR) | 44 (33–56) | 47 (34–58) | 44 (34–54) | 35 (29–44) |
Male | 12 266 (53.7) | 6675 (51.2) | 3812 (61.7) | 1779 (49.1) |
Female | 10 574 (46.3) | 6364 (48.8) | 2362 (38.3) | 1848 (50.9) |
Race/Ethnicity | ||||
Non-Hispanic White | 17 654 (79.6) | 10 832 (85.4) | 3869 (64.6) | 2953 (84.1) |
Non-Hispanic Black | 2619 (11.8) | 892 (7.0) | 1511 (25.2) | 216 (6.2) |
Hispanic | 1914 (8.6) | 958 (7.6) | 614 (10.2) | 342 (9.7) |
Insurance | ||||
Medicare | 6968 (30.5) | 5187 (39.8) | 1324 (21.4) | 457 (12.6) |
Medicaid | 5964 (26.1) | 3030 (23.2) | 1998 (32.4) | 936 (25.8) |
Private | 2610 (11.4) | 1682 (12.9) | 545 (8.8) | 383 (10.6) |
Uninsured | 7298 (32.0) | 3140 (24.1) | 2307 (37.4) | 1851 (51.0) |
Infection | ||||
Endocarditis | 2207 (9.7) | 1238 (9.5) | 388 (6.3) | 581 (16.0) |
SSTI | 11 302 (49.5) | 6081 (46.6) | 3199 (51.8) | 2022 (55.8) |
Osteomyelitis | 3240 (14.2) | 2084 (16.0) | 709 (11.5) | 447 (12.3) |
Sepsis/Bacteremia | 11 915 (52.2) | 7062 (54.2) | 3069 (49.7) | 1784 (49.2) |
Comorbidity Present | ||||
HIV-positive | 1085 (4.8) | 295 (2.3) | 649 (10.5) | 141 (3.9) |
HCV-positive | 5925 (25.9) | 2962 (22.7) | 1350 (21.9) | 1613 (44.3) |
Heart Failure | 2268 (9.9) | 1443 (11.1) | 655 (10.6) | 170 (4.7) |
Hypertension | 8844 (38.7) | 5638 (43.2) | 2424 (39.3) | 782 (21.5) |
Chronic Pulmonary Disease | 4277 (18.7) | 2926 (22.4) | 1045 (16.9) | 306 (8.4) |
Diabetes | 4620 (20.2) | 3103 (23.8) | 1217 (19.7) | 300 (8.2) |
Renal Disease | 2577 (11.3) | 1733 (13.3) | 688 (11.1) | 156 (4.3) |
Alcohol | 2726 (11.9) | 1092 (8.4) | 1204 (19.5) | 430 (11.8) |
Psychoses | 994 (4.4) | 290 (2.2) | 537 (8.7) | 167 (4.6) |
Depression | 4879 (21.4) | 3066 (23.5) | 1088 (17.6) | 725 (19.9) |
Overdose | 1563 (6.8) | 963 (7.4) | 293 (4.8) | 307 (8.5) |
Length of stay (median, IQR) | 6.0 (3–12) | 6.0 (3–13) | 5.0 (3–10) | 5.0 (2–11) |
Disposition | ||||
Discharged | 18 572 (81.3) | 10 962 (84.1) | 4978 (80.6) | 2632 (72.3) |
In-hospital mortality | 823 (3.6) | 458 (3.5) | 264 (4.3) | 101 (2.8) |
Patient-directed discharge | 3461 (15.1) | 1619 (12.4) | 932 (15.1) | 910 (25.0) |
Characteristic . | Overall, n (%) N = 22 856 . | Opioids-only, n (%) n = 13 039 . | Stimulant-only, N (%) n = 6174 . | Opioid/Stimulant, N (%) n = 3643 . |
---|---|---|---|---|
Age | ||||
18–34 | 6665 (31.1) | 3310 (27.1) | 1645 (28.4) | 1710 (49.5) |
35–54 | 9347 (43.6) | 4882 (40.0) | 2971 (51.3) | 1494 (43.2) |
55–64 | 3896 (18.2) | 2648 (21.7) | 1018 (17.6) | 230 (6.7) |
65–75 | 1554 (7.3) | 1375 (11.3) | 155 (2.7) | 24 (0.7) |
Age (median, IQR) | 44 (33–56) | 47 (34–58) | 44 (34–54) | 35 (29–44) |
Male | 12 266 (53.7) | 6675 (51.2) | 3812 (61.7) | 1779 (49.1) |
Female | 10 574 (46.3) | 6364 (48.8) | 2362 (38.3) | 1848 (50.9) |
Race/Ethnicity | ||||
Non-Hispanic White | 17 654 (79.6) | 10 832 (85.4) | 3869 (64.6) | 2953 (84.1) |
Non-Hispanic Black | 2619 (11.8) | 892 (7.0) | 1511 (25.2) | 216 (6.2) |
Hispanic | 1914 (8.6) | 958 (7.6) | 614 (10.2) | 342 (9.7) |
Insurance | ||||
Medicare | 6968 (30.5) | 5187 (39.8) | 1324 (21.4) | 457 (12.6) |
Medicaid | 5964 (26.1) | 3030 (23.2) | 1998 (32.4) | 936 (25.8) |
Private | 2610 (11.4) | 1682 (12.9) | 545 (8.8) | 383 (10.6) |
Uninsured | 7298 (32.0) | 3140 (24.1) | 2307 (37.4) | 1851 (51.0) |
Infection | ||||
Endocarditis | 2207 (9.7) | 1238 (9.5) | 388 (6.3) | 581 (16.0) |
SSTI | 11 302 (49.5) | 6081 (46.6) | 3199 (51.8) | 2022 (55.8) |
Osteomyelitis | 3240 (14.2) | 2084 (16.0) | 709 (11.5) | 447 (12.3) |
Sepsis/Bacteremia | 11 915 (52.2) | 7062 (54.2) | 3069 (49.7) | 1784 (49.2) |
Comorbidity Present | ||||
HIV-positive | 1085 (4.8) | 295 (2.3) | 649 (10.5) | 141 (3.9) |
HCV-positive | 5925 (25.9) | 2962 (22.7) | 1350 (21.9) | 1613 (44.3) |
Heart Failure | 2268 (9.9) | 1443 (11.1) | 655 (10.6) | 170 (4.7) |
Hypertension | 8844 (38.7) | 5638 (43.2) | 2424 (39.3) | 782 (21.5) |
Chronic Pulmonary Disease | 4277 (18.7) | 2926 (22.4) | 1045 (16.9) | 306 (8.4) |
Diabetes | 4620 (20.2) | 3103 (23.8) | 1217 (19.7) | 300 (8.2) |
Renal Disease | 2577 (11.3) | 1733 (13.3) | 688 (11.1) | 156 (4.3) |
Alcohol | 2726 (11.9) | 1092 (8.4) | 1204 (19.5) | 430 (11.8) |
Psychoses | 994 (4.4) | 290 (2.2) | 537 (8.7) | 167 (4.6) |
Depression | 4879 (21.4) | 3066 (23.5) | 1088 (17.6) | 725 (19.9) |
Overdose | 1563 (6.8) | 963 (7.4) | 293 (4.8) | 307 (8.5) |
Length of stay (median, IQR) | 6.0 (3–12) | 6.0 (3–13) | 5.0 (3–10) | 5.0 (2–11) |
Disposition | ||||
Discharged | 18 572 (81.3) | 10 962 (84.1) | 4978 (80.6) | 2632 (72.3) |
In-hospital mortality | 823 (3.6) | 458 (3.5) | 264 (4.3) | 101 (2.8) |
Patient-directed discharge | 3461 (15.1) | 1619 (12.4) | 932 (15.1) | 910 (25.0) |
Abbreviations: HCV, hepatitis C virus; HIV, human immunodeficiency virus; IQR, interquartile range; SSTI, skin and soft tissue infection.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.